MX2008012905A - Compuestos de naftalendiona. - Google Patents

Compuestos de naftalendiona.

Info

Publication number
MX2008012905A
MX2008012905A MX2008012905A MX2008012905A MX2008012905A MX 2008012905 A MX2008012905 A MX 2008012905A MX 2008012905 A MX2008012905 A MX 2008012905A MX 2008012905 A MX2008012905 A MX 2008012905A MX 2008012905 A MX2008012905 A MX 2008012905A
Authority
MX
Mexico
Prior art keywords
naphthalenedione
naphthalenedione compounds
compounds
compositions
psoriasis
Prior art date
Application number
MX2008012905A
Other languages
English (en)
Inventor
Du-Shieng Chien
Yi-Wen Chu
Wu-Chang Chuang
Ming-Chung Lee
Original Assignee
Sunten Phytotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunten Phytotech Co Ltd filed Critical Sunten Phytotech Co Ltd
Publication of MX2008012905A publication Critical patent/MX2008012905A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/02—Quinones with monocyclic quinoid structure
    • C07C50/06—Quinones with monocyclic quinoid structure with unsaturation outside the quinoid structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se relaciona a composiciones que contienen un compuesto de la fórmula (I). Cada variable se define en la especificación. También se divulgan métodos para usar estas composiciones para tratar acné, psoriasis y úlcera de la piel infecciosa.
MX2008012905A 2006-04-07 2007-04-09 Compuestos de naftalendiona. MX2008012905A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79025906P 2006-04-07 2006-04-07
PCT/US2007/066225 WO2007118227A2 (en) 2006-04-07 2007-04-09 Naphthalenedione compounds

Publications (1)

Publication Number Publication Date
MX2008012905A true MX2008012905A (es) 2009-02-20

Family

ID=38581859

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008012905A MX2008012905A (es) 2006-04-07 2007-04-09 Compuestos de naftalendiona.

Country Status (13)

Country Link
US (1) US7622506B2 (es)
EP (1) EP2004174A4 (es)
JP (1) JP2009522379A (es)
KR (1) KR101007782B1 (es)
CN (1) CN101484155A (es)
AU (2) AU2007234746B2 (es)
BR (1) BRPI0709477A2 (es)
CA (1) CA2635311C (es)
MX (1) MX2008012905A (es)
RU (1) RU2426538C2 (es)
TW (1) TWI394565B (es)
WO (1) WO2007118227A2 (es)
ZA (1) ZA200808549B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2184997A4 (en) 2007-07-31 2010-11-03 Univ New York DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES
CN102491897A (zh) * 2011-12-13 2012-06-13 南京大学 紫草宁含氟羧酸酯类衍生物及其合成方法和应用
CN106806367A (zh) * 2015-09-29 2017-06-09 王洪燕 一种治疗烧伤后感染的药物组合物
CN115969824B (zh) * 2023-03-02 2024-05-10 扬州大学 紫草萘醌衍生物及其与抗生素联用在制备治疗细菌感染疾病药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1165509C (zh) 2002-03-19 2004-09-08 中山大学 紫草萘醌类衍生物及其在制备抗癌药物中的应用
DE60330914D1 (de) * 2003-02-21 2010-02-25 Beijing Jbc Chinese Traditiona Arzneimittel mit shikonin als wirkstoff
US20050222258A1 (en) * 2003-02-21 2005-10-06 Feixin Wang Pharmaceuticals comprising shikonins as active constituent
CN100455283C (zh) 2003-05-08 2009-01-28 北京金本草中药科技发展有限公司 含有阿卡宁类化合物作为活性成分的药物
CN1271032C (zh) 2003-12-04 2006-08-23 上海交通大学 作为免疫抑制剂的紫草素衍生物及其金属络合物

Also Published As

Publication number Publication date
TWI394565B (zh) 2013-05-01
JP2009522379A (ja) 2009-06-11
US20070238782A1 (en) 2007-10-11
KR20080103569A (ko) 2008-11-27
CN101484155A (zh) 2009-07-15
WO2007118227A3 (en) 2008-11-20
US7622506B2 (en) 2009-11-24
ZA200808549B (en) 2009-10-28
EP2004174A4 (en) 2010-07-28
AU2007234746A1 (en) 2007-10-18
CA2635311A1 (en) 2007-10-18
RU2426538C2 (ru) 2011-08-20
EP2004174A2 (en) 2008-12-24
KR101007782B1 (ko) 2011-01-14
AU2007234746A8 (en) 2008-07-17
AU2007234746B2 (en) 2009-10-01
RU2008144133A (ru) 2010-05-20
CA2635311C (en) 2012-08-14
WO2007118227A2 (en) 2007-10-18
BRPI0709477A2 (pt) 2011-05-10
TW200816984A (en) 2008-04-16
AU2010200026A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
NZ597517A (en) 5-fluoropyrimidinone derivatives
WO2007085895A3 (en) Fap inhibitors
TW200716557A (en) Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
TW200602808A (en) Functionalized photoinitiators
NZ596583A (en) Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
EP3586631A3 (en) Plant health composition
MX2009007231A (es) Compuestos quimicos 637:piridopirimidindionas como inhibidores de la fosfodiesterasa 4.
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
NZ601350A (en) Method of treating arthritis
NZ579928A (en) Fluorinated derivatives of deferiprone
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs
MX2009011205A (es) Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide.
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
AU2009319796A8 (en) Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers
GB0508314D0 (en) Organic compounds
ZA200802848B (en) Potassium channel inhibitors
PL1833477T3 (pl) Związki pirazolo-heteroarylowe użyteczne do leczenia chorób, w których pośredniczą TNF-ALFA i IL-1
MX2009000420A (es) Derivados de isoindolina para el tratamiento de arritmias.
MX2009012374A (es) Compuestos novedosos como ligandos del receptor de canabinoides.
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
UA107562C2 (uk) Спосіб лікування псоріазу
ME00961B (me) Derivati-7 alkinil-1,8-naftiridoni, njihova priprema i njihova primjena u liječenju
WO2009124962A3 (en) Sulfonamides

Legal Events

Date Code Title Description
FG Grant or registration